Program
- Program 2022
- Program 2021
Accreditation 2021
Scholarships
- Scholarships
Exhibitors and Sponsors
Abstracts
- Abstracts 2021
  - Published Abstracts HDI
  - Published Abstracts SAGE
Program Organizers

Menu

Program
- Program 2022
- Program 2021
Accreditation 2021
Scholarships
- Scholarships
Exhibitors and Sponsors
Abstracts
- Abstracts 2021
  - Published Abstracts HDI
  - Published Abstracts SAGE
Program Organizers

Conversion of Cinacalcet to Etelcalcetide for Uncontrolled Hyperparathyroidism in Hemodialysis Patients – Abdullah Hamad, md

Annual Dialysis Conference > Posters > Adult > Conversion of Cinacalcet to Etelcalcetide for Uncontrolled Hyperparathyroidism in Hemodialysis Patients – Abdullah Hamad, md

Adult

January 13, 2022 By mimhav

1090 2022 Adult

Previous

Body Composition Monitor in Assessment of Nutritional Status in Hemodialysis Patients in a Tertiary Hospital - Sonja Escara, MD

Body Composition Monitor in Assessment of Nutritional Status in Hemodialysis Patients in a Tertiary Hospital - Sonja Escara, MD

Next

Serum Levels of Essential Elements Mg , Zn and Toxic Elements Pb ,Cd in Different Stages of CKD - MM Iqbal, MBBS

Serum Levels of Essential Elements Mg , Zn and Toxic Elements Pb ,Cd in Different Stages of CKD - MM Iqbal, MBBS

Presented in cooperation with

Contact

314-516-8419
Conferences@mimh.edu

Program
- Program 2022
- Program 2021
Accreditation 2021
Scholarships
- Scholarships
Exhibitors and Sponsors
Abstracts
- Abstracts 2021
  - Published Abstracts HDI
  - Published Abstracts SAGE
Program Organizers